Overview
The goal of this behavioral-interventional study is to learn if the Abecedarian Approach implemented virtually for children ages 0-5 with a history of Hypoxic Ischaemic Encephalopathy (HIE) and/or premature birth produces the same effects as when administered at in-person facilities.
Eligibility
Inclusion Criteria:
- IPNH-NDCP patients, including:
- Term-born children diagnosed during the neonatal period with hypoxic-ischemic encephalopathy, or
- premature children (born at less than 28 weeks gestational age).
- Parent or legal guardian will also be enrolled as a participant
- Parents must be English-speaking (able to provide consent and complete questionnaires).
Exclusion Criteria:
- Not suitable for study participation due to other reasons at the discretion of the investigator.
- Infants with chromosomal abnormalities, genetic syndromes (for example, such as Down Syndrome or Trisomy18) and major congenital malformations will be excluded.
- Infants with vision impairment will also be excluded from the study, as our study procedures do require intact vision to be able to complete.
- For parents or legal guardians, there are no exclusion criteria.